Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Mt-1303
1. 942399-20-4
2. Amiselimod [inn]
3. Amiselimod Free Base
4. Amiselimod(mt-1303) Free Base
5. 942399-20-4 (free Base)
6. 358m5150ly
7. 2-amino-2-(4-(heptyloxy)-3-(trifluoromethyl)phenethyl)propane-1,3-diol
8. 2-amino-2-(2-(4-heptyloxy-3-trifluoromethylphenyl)ethyl)propane-1,3-diol
9. Amiselimod, Mt-1303
10. 2-amino-2-[2-[4-heptoxy-3-(trifluoromethyl)phenyl]ethyl]propane-1,3-diol
11. 2-amino-2-{2-[4-(heptyloxy)-3-(trifluoromethyl)phenyl]ethyl}propane-1,3-diol
12. Unii-358m5150ly
13. Amiselimod,mt1303
14. Amiselimod (usan/inn)
15. Amiselimod [usan]
16. Amiselimod [who-dd]
17. Mt-1303 Free Base
18. Gtpl9319
19. Schembl2463680
20. Chembl3707375
21. Dtxsid301141402
22. Bcp24738
23. Ex-a1427
24. Mt1303
25. Zinc43170189
26. Akos032971355
27. Example 1 [us20090137530]
28. D10905
29. Mt-1303; Mt1303; Mt 1303
30. Q27256444
31. 1,3-propanediol, 2-amino-2-(2-(4-(heptyloxy)-3-(trifluoromethyl)phenyl)ethyl)-
32. 2-amino-2-[2-[4-(heptyloxy)-3-(trifluoromethyl)phenyl]ethyl]-1,3-propanediol
| Molecular Weight | 377.4 g/mol |
|---|---|
| Molecular Formula | C19H30F3NO3 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 12 |
| Exact Mass | 377.21777831 g/mol |
| Monoisotopic Mass | 377.21777831 g/mol |
| Topological Polar Surface Area | 75.7 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 376 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
49
PharmaCompass offers a list of Amiselimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amiselimod manufacturer or Amiselimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amiselimod manufacturer or Amiselimod supplier.
PharmaCompass also assists you with knowing the Amiselimod API Price utilized in the formulation of products. Amiselimod API Price is not always fixed or binding as the Amiselimod Price is obtained through a variety of data sources. The Amiselimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Amiselimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amiselimod, including repackagers and relabelers. The FDA regulates Amiselimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amiselimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Amiselimod supplier is an individual or a company that provides Amiselimod active pharmaceutical ingredient (API) or Amiselimod finished formulations upon request. The Amiselimod suppliers may include Amiselimod API manufacturers, exporters, distributors and traders.
Amiselimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amiselimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amiselimod GMP manufacturer or Amiselimod GMP API supplier for your needs.
A Amiselimod CoA (Certificate of Analysis) is a formal document that attests to Amiselimod's compliance with Amiselimod specifications and serves as a tool for batch-level quality control.
Amiselimod CoA mostly includes findings from lab analyses of a specific batch. For each Amiselimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amiselimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Amiselimod EP), Amiselimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amiselimod USP).
